Article
Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
Cancer gene therapy - 1 Jun 2016
Wang Z, Liao J, Wu S, Li C, Fan J, Peng Z
Abstract excerpt
Hepatocellular carcinoma (HCC) recurrence is one of the leading causes of death after orthotopic liver transplantation (OLT). The sixth complement component (C6) is a late-acting complement protein that participates in the assembly of the membrane attack complex, which has an indispensable role in innate and acquired immune responses, as well as cancer immune surveillance. However, studies assessing the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
